UBC Opens Office In Germany

Thursday, July 1, 2010 07:59 AM

United BioSource Corporation (UBC) launched a new office in Lörrach, Germany, further expanding the company’s clinical research and medical affairs capabilities in Europe.

The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.

The new office will be led by Hazel Wohlfahrt, executive director of Clinical Services, Europe. Wohlfahrt has coordinated and led large international clinical studies and registries, covering all countries in Europe and is a recognized leader in German speaking countries.

“Our new office brings together clinical research experts in project and site management and monitoring with many decades of combined experience designing and executing successful product development programs,” said Sean Hart, UBC’s general manager for Clinical Services.

The project and site management teams based in Lörrach have experience in a broad range of therapeutic areas. Key capabilities include study planning, study monitoring, biometrics, and execution of phase II–IV clinical studies, registries and observational studies. The project and site management team members are all bi-lingual in German and English and collectively, they have experience in the areas of neurology, oncology, epidemiology, cardiology, hematology and pediatrics.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs